Webinar: Non-invasive Assessment of Clinically Significant Portal Hypertension

Date: Monday, December 12, 3:00 pm - 4:00 pm (EST)
Presenters: Annalis Berzigotti, MD, PhD | Maja Thiele, MD, PhD
Moderator: Atoosa Rabiee, MD

There is emerging data showing benefits of diagnosing clinically significant portal hypertension and its treatment to prevent decompensation. The field is rapidly evolving, specifically with respect to non-invasive modalities of measurement. This webinar will review currently available non-invasive tests to measure clinically significant portal hypertension including blood tests, liver stiffness and spleen stiffness. Use of non-invasive measurements in special populations such as those with fatty liver disease and those who have achieved sustained virological response as well as how to monitor improvements in clinically significant portal hypertension without ongoing injury are also areas of interest which will be addressed. 

About the Presenters

Annalis Berzigotti, MD, PhD

Maja Thiele, MD, PhD

Dr. Maja Thiele works to reduce morbidity and mortality from alcohol-related liver disease, for the benefit of an otherwise stigmatized patient group. Her research centers on the development and validation of diagnostic and prognostic biomarkers, with a particular focus on early disease detection, cost-effective referral pathways and omics technologies. Elastography expert contributor to EASL Clinical Practice Guidance, the BAVENO VII consensus statement, and AASLD clinical guidance. Partner in the European research consortia GALAXY, LiverScreen, MicrobPredict and SALVE.

About the Moderator

Atoosa Rabiee, MD

Originally from Iran, Dr. Atoosa Rabiee is a graduate of Tehran University of Medical Sciences. In the USA, she completed two year of research fellowship on T32 grant prior to applying for residency. She then finished her internal medicine residency at Johns Hopkins Bayview Medical Center, followed by gastroenterology fellowship at University of Miami Jackson Memorial hospital. She graduated from transplant hepatology fellowship at Johns Hopkins hospital in 2017 and joined the VA in Washington DC right after and now serves as the clinical director of hepatology and chief of transplant services. Her main interests include portal hypertension and hepatocellular carcinoma.